Since the DNA-damage promoting chemotherapeutic Adriamycin (ADR) has been shown to induce PARP-1 cleavage and apoptosis in a number of cancer cells [25], our WB analysis also revealed cleavage of PARP in Daoy cells following treatment with ADR in a dose and time-dependent manner (Figure 2C). Here, PARP1 is linked to cancer.